Randomized Double Blind Placebo Control Study in Patients with Schizophrenia

Clinical trial NCT01602029 · COMPLETED

Trial details

NCT number: NCT01602029
Sponsor: Pakistan Institute of Living and Learning
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Psychosis Not Otherwise Specified Schizophreniform Disorder

Start date: 2010-08-01
Primary completion: 2013-06-01
Enrollment: 303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.